Dids / Achievements
- EMP is represented in several EMEA committees:
– Code of Conduct, concerning the relationships between patients' associations and the pharmaceutical industry;
– Previously, we worked on a program related to managing the risks of Thalidomide.
– We also participated on a program for risk management of Lenalidomide;
– Several EMP members received special training from EMEA.
- Representation at relevant European health authorities;
- Collaboration with relevant European and international Organisations;
- Provision of information via the web-site;
- National Health Authorities: each member organisation is active in its own country with respect to implementation of new registered medication, reimbursement problems etc.;
- Organisation of Symposia, workshops etc.
Graz, Austria: June ’08: Second EU Int. MM workshop
Maastricht, the Netherlands: Oct. ’08: ‘No Policy without Patients’:
Aim: to demonstrate the need and the role of patient organizations', as full stakeholders, in the development of health policies.
The Symposium was followed by a Round Table Conference during which conclusions were drawn in view of a strategy plan.
Result: The final report can be downloaded here.